Ensign 投資者消息：若您因 The Ensign Group, Inc. (NASDAQ: ENSG) 蒙受損失，請聯絡 Rosen Law Firm 了解您的權益

Rosen Law Firm is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potentially issuing materially misleading business information to investors. The investigation was triggered by a short-seller report from Hunterbrook alleging that Ensign's profitability model relies on reducing patient care quality and manipulating quality scores. Following the report's release on June 8, 2026, Ensign's stock price declined 8.15%. The firm is preparing a class action lawsuit and inviting affected investors to join.